Across four parts of the “FDA Watch” podcast series featuring Skadden partners and counsel, legal and industry panelists convened between March ...
The One Big Beautiful Bill Act (OBBBA), when signed into law on July 4, 2025, imposed a number of new restrictions and requirements on energy ...
In one of the most significant class action rulings in website tracking litigation to date, a California federal court just ...
Antitrust authorities in the United States, Europe and Asia have shown increased openness to merger remedies, including behavioral ones.
Bank regulators have signaled a renewed openness to de novo bank charter applications, creating new opportunities for fintech ...
The latest Weekly Sweep highlights significant developments from across the Northeast involving debt collection enforcement, auto finance ...
Drug developers face new regulatory uncertainty because the status of a number of ambitious changes to FDA’s review processes are in doubt following the departure of Commissioner Marty Makary and many ...
Spinal cord injuries from traumatic accidents can have devastating consequences. They can lead to chronic pain and permanent ...
In this episode, Gabe Scott, Kevin Alonso, and Cindy Laura Ortega Ramos unpack recent updates to the federal independent dispute resolution ...
Each year the New Jersey Bureau of Securities (the “Bureau”) publishes an examination that all New Jersey registered ...
This briefing note looks in detail at the proposed amendments to the Trusts (Guernsey) Law, 2007. These proposals are ...
US Government Directive Compels Anthropic to Shut Down Two Advanced AI Models On June 12, 2026, Anthropic announced that the US government had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results